Literature DB >> 7772597

Nucleophosmin/B23 (NPM) oligomer is a major and stable entity in HeLa cells.

P K Chan1, F Y Chan.   

Abstract

HeLa cell extract was separated by 7% polyacrylamide gel electrophoresis without SDS and subsequently stained with anti-nucleophosmin/B23 (NPM) antibody in a Western blot analysis. Two immunobands were obtained. The major band with a slower electromobility (RF = 0.23) is the NPM oligomer, while the fast-moving minor band is the monomer (RF = 0.56). The oligomer constitutes about 95% of total NPM. The oligomer sedimented faster (10 s) than the monomer in sucrose density gradient centrifugation. Three oligomer bands were identified. NPM oligomer is not affected by treatments with DNase. RNase, 10 mM EDTA, 1 M NaCl, and lyophilization. However, 3 M urea causes reversible dissociation of NPM oligomer into monomer. The level of NPM oligomer remains unchanged in HeLa cells after treatment with the cytotoxic agents, actinomycin D, toyocamycin and camptothecin. These results indicate that NPM oligomer is the major and stable NPM entity in HeLa cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7772597     DOI: 10.1016/0167-4781(95)00044-h

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

Review 1.  Nucleophosmin and human cancer.

Authors:  Mi Jung Lim; Xin Wei Wang
Journal:  Cancer Detect Prev       Date:  2006-11-17

2.  A novel helicase-type protein in the nucleolus: protein NOH61.

Authors:  R F Zirwes; J Eilbracht; S Kneissel; M S Schmidt-Zachmann
Journal:  Mol Biol Cell       Date:  2000-04       Impact factor: 4.138

3.  G protein-coupled receptor kinase 5 phosphorylates nucleophosmin and regulates cell sensitivity to polo-like kinase 1 inhibition.

Authors:  Christopher H So; Allison M Michal; Rouzbeh Mashayekhi; Jeffrey L Benovic
Journal:  J Biol Chem       Date:  2012-03-30       Impact factor: 5.157

4.  p130Cas mediates the transforming properties of the anaplastic lymphoma kinase.

Authors:  Chiara Ambrogio; Claudia Voena; Andrea D Manazza; Roberto Piva; Ludovica Riera; Laura Barberis; Carlotta Costa; Guido Tarone; Paola Defilippi; Emilio Hirsch; Elisabetta Boeri Erba; Shabaz Mohammed; Ole N Jensen; Giorgio Palestro; Giorgio Inghirami; Roberto Chiarle
Journal:  Blood       Date:  2005-08-16       Impact factor: 22.113

5.  NPM1/B23: A Multifunctional Chaperone in Ribosome Biogenesis and Chromatin Remodeling.

Authors:  Mikael S Lindström
Journal:  Biochem Res Int       Date:  2010-10-05

6.  Targeting nucleophosmin 1 represents a rational strategy for radiation sensitization.

Authors:  Konjeti R Sekhar; Mouadh Benamar; Amudhan Venkateswaran; Soumya Sasi; Narsimha R Penthala; Peter A Crooks; Stephen R Hann; Ling Geng; Ramesh Balusu; Tarek Abbas; Michael L Freeman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-07-08       Impact factor: 7.038

7.  Ribosomal protein S9 is a novel B23/NPM-binding protein required for normal cell proliferation.

Authors:  Mikael S Lindström; Yanping Zhang
Journal:  J Biol Chem       Date:  2008-04-17       Impact factor: 5.157

8.  Nucleophosmin is a binding partner of nucleostemin in human osteosarcoma cells.

Authors:  Hanhui Ma; Thoru Pederson
Journal:  Mol Biol Cell       Date:  2008-04-30       Impact factor: 4.138

Review 9.  Anaplastic lymphoma kinase: Role in cancer and therapy perspective.

Authors:  Zhihong Zhao; Vivek Verma; Mutian Zhang
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

10.  Cucurbitacin B inhibits human breast cancer cell proliferation through disruption of microtubule polymerization and nucleophosmin/B23 translocation.

Authors:  Suwit Duangmano; Phorntip Sae-Lim; Apichart Suksamrarn; Frederick E Domann; Pimpicha Patmasiriwat
Journal:  BMC Complement Altern Med       Date:  2012-10-12       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.